Delaware-based NiKang Theraputics secures $200 million in series B funding

Delaware Business Now

Jun 10, 2021

Reading Time: < 1 minute Delaware-based NiKang Therapeutics Inc. completed an oversubscribed $200 million series C financing. Last year, the company received $50 million in series…